Global and Japan Corticosteroid Injections for Joint Pain Market Insights, Forecast to 2027

Global and Japan Corticosteroid Injections for Joint Pain Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Corticosteroid Injections for Joint Pain Product Introduction
1.2 Market by Type
1.2.1 Global Corticosteroid Injections for Joint Pain Market Size Growth Rate by Type
1.2.2 Knee & Ankle
1.2.3 Hip Joint
1.2.4 Shoulder & Elbow
1.2.5 Facet Joints of the Spine
1.2.6 Others
1.3 Market by Application
1.3.1 Global Corticosteroid Injections for Joint Pain Market Size Growth Rate by Application
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Corticosteroid Injections for Joint Pain Market Size, Estimates and Forecasts
2.1.1 Global Corticosteroid Injections for Joint Pain Revenue 2016-2027
2.1.2 Global Corticosteroid Injections for Joint Pain Sales 2016-2027
2.2 Global Corticosteroid Injections for Joint Pain, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Corticosteroid Injections for Joint Pain Historical Market Size by Region (2016-2021)
2.3.1 Global Corticosteroid Injections for Joint Pain Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Corticosteroid Injections for Joint Pain Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Corticosteroid Injections for Joint Pain Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Corticosteroid Injections for Joint Pain Sales Forecast by Region (2022-2027)
2.4.2 Global Corticosteroid Injections for Joint Pain Revenue Forecast by Region (2022-2027)
3 Global Corticosteroid Injections for Joint Pain Competitor Landscape by Players
3.1 Global Top Corticosteroid Injections for Joint Pain Manufacturers by Sales
3.1.1 Global Corticosteroid Injections for Joint Pain Sales by Manufacturer (2016-2021)
3.1.2 Global Corticosteroid Injections for Joint Pain Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Corticosteroid Injections for Joint Pain Manufacturers by Revenue
3.2.1 Key Corticosteroid Injections for Joint Pain Manufacturers Covered: Ranking by Revenue
3.2.2 Global Corticosteroid Injections for Joint Pain Revenue by Manufacturers (2016-2021)
3.2.3 Global Corticosteroid Injections for Joint Pain Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Corticosteroid Injections for Joint Pain Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Corticosteroid Injections for Joint Pain Revenue in 2020
3.2.6 Global Corticosteroid Injections for Joint Pain Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Corticosteroid Injections for Joint Pain Price by Manufacturers
3.4 Global Corticosteroid Injections for Joint Pain Manufacturing Base Distribution, Product Types
3.4.1 Corticosteroid Injections for Joint Pain Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Corticosteroid Injections for Joint Pain Product Type
3.4.3 Date of International Manufacturers Enter into Corticosteroid Injections for Joint Pain Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Corticosteroid Injections for Joint Pain Market Size by Type (2016-2021)
4.1.1 Global Corticosteroid Injections for Joint Pain Sales by Type (2016-2021)
4.1.2 Global Corticosteroid Injections for Joint Pain Revenue by Type (2016-2021)
4.1.3 Corticosteroid Injections for Joint Pain Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Corticosteroid Injections for Joint Pain Market Size Forecast by Type (2022-2027)
4.2.1 Global Corticosteroid Injections for Joint Pain Sales Forecast by Type (2022-2027)
4.2.2 Global Corticosteroid Injections for Joint Pain Revenue Forecast by Type (2022-2027)
4.2.3 Corticosteroid Injections for Joint Pain Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Corticosteroid Injections for Joint Pain Market Size by Application (2016-2021)
5.1.1 Global Corticosteroid Injections for Joint Pain Sales by Application (2016-2021)
5.1.2 Global Corticosteroid Injections for Joint Pain Revenue by Application (2016-2021)
5.1.3 Corticosteroid Injections for Joint Pain Price by Application (2016-2021)
5.2 Corticosteroid Injections for Joint Pain Market Size Forecast by Application (2022-2027)
5.2.1 Global Corticosteroid Injections for Joint Pain Sales Forecast by Application (2022-2027)
5.2.2 Global Corticosteroid Injections for Joint Pain Revenue Forecast by Application (2022-2027)
5.2.3 Global Corticosteroid Injections for Joint Pain Price Forecast by Application (2022-2027)
6 Japan by Players, Type and Application
6.1 Japan Corticosteroid Injections for Joint Pain Market Size YoY Growth 2016-2027
6.1.1 Japan Corticosteroid Injections for Joint Pain Sales YoY Growth 2016-2027
6.1.2 Japan Corticosteroid Injections for Joint Pain Revenue YoY Growth 2016-2027
6.1.3 Japan Corticosteroid Injections for Joint Pain Market Share in Global Market 2016-2027
6.2 Japan Corticosteroid Injections for Joint Pain Market Size by Players (International and Local Players)
6.2.1 Japan Top Corticosteroid Injections for Joint Pain Players by Sales (2016-2021)
6.2.2 Japan Top Corticosteroid Injections for Joint Pain Players by Revenue (2016-2021)
6.3 Japan Corticosteroid Injections for Joint Pain Historic Market Review by Type (2016-2021)
6.3.1 Japan Corticosteroid Injections for Joint Pain Sales Market Share by Type (2016-2021)
6.3.2 Japan Corticosteroid Injections for Joint Pain Revenue Market Share by Type (2016-2021)
6.3.3 Japan Corticosteroid Injections for Joint Pain Price by Type (2016-2021)
6.4 Japan Corticosteroid Injections for Joint Pain Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Corticosteroid Injections for Joint Pain Sales Forecast by Type (2022-2027)
6.4.2 Japan Corticosteroid Injections for Joint Pain Revenue Forecast by Type (2022-2027)
6.4.3 Japan Corticosteroid Injections for Joint Pain Price Forecast by Type (2022-2027)
6.5 Japan Corticosteroid Injections for Joint Pain Historic Market Review by Application (2016-2021)
6.5.1 Japan Corticosteroid Injections for Joint Pain Sales Market Share by Application (2016-2021)
6.5.2 Japan Corticosteroid Injections for Joint Pain Revenue Market Share by Application (2016-2021)
6.5.3 Japan Corticosteroid Injections for Joint Pain Price by Application (2016-2021)
6.6 Japan Corticosteroid Injections for Joint Pain Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Corticosteroid Injections for Joint Pain Sales Forecast by Application (2022-2027)
6.6.2 Japan Corticosteroid Injections for Joint Pain Revenue Forecast by Application (2022-2027)
6.6.3 Japan Corticosteroid Injections for Joint Pain Price Forecast by Application (2022-2027)
7 North America
7.1 North America Corticosteroid Injections for Joint Pain Market Size YoY Growth 2016-2027
7.2 North America Corticosteroid Injections for Joint Pain Market Facts & Figures by Country
7.2.1 North America Corticosteroid Injections for Joint Pain Sales by Country (2016-2021)
7.2.2 North America Corticosteroid Injections for Joint Pain Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Corticosteroid Injections for Joint Pain Market Size YoY Growth 2016-2027
8.2 Asia Pacific Corticosteroid Injections for Joint Pain Market Facts & Figures by Region
8.2.1 Asia Pacific Corticosteroid Injections for Joint Pain Sales by Region (2016-2021)
8.2.2 Asia Pacific Corticosteroid Injections for Joint Pain Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Corticosteroid Injections for Joint Pain Market Size YoY Growth 2016-2027
9.2 Europe Corticosteroid Injections for Joint Pain Market Facts & Figures by Country
9.2.1 Europe Corticosteroid Injections for Joint Pain Sales by Country (2016-2021)
9.2.2 Europe Corticosteroid Injections for Joint Pain Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Corticosteroid Injections for Joint Pain Market Size YoY Growth 2016-2027
10.2 Latin America Corticosteroid Injections for Joint Pain Market Facts & Figures by Country
10.2.1 Latin America Corticosteroid Injections for Joint Pain Sales by Country (2016-2021)
10.2.2 Latin America Corticosteroid Injections for Joint Pain Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Corticosteroid Injections for Joint Pain Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Corticosteroid Injections for Joint Pain Market Facts & Figures by Country
11.2.1 Middle East and Africa Corticosteroid Injections for Joint Pain Sales by Country (2016-2021)
11.2.2 Middle East and Africa Corticosteroid Injections for Joint Pain Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Allergan
12.1.1 Allergan Corporation Information
12.1.2 Allergan Description and Business Overview
12.1.3 Allergan Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Allergan Corticosteroid Injections for Joint Pain Products Offered
12.1.5 Allergan Recent Development
12.2 Pfizer
12.2.1 Pfizer Corporation Information
12.2.2 Pfizer Description and Business Overview
12.2.3 Pfizer Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Pfizer Corticosteroid Injections for Joint Pain Products Offered
12.2.5 Pfizer Recent Development
12.3 Sanofi
12.3.1 Sanofi Corporation Information
12.3.2 Sanofi Description and Business Overview
12.3.3 Sanofi Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Sanofi Corticosteroid Injections for Joint Pain Products Offered
12.3.5 Sanofi Recent Development
12.4 Anika Therapeutics
12.4.1 Anika Therapeutics Corporation Information
12.4.2 Anika Therapeutics Description and Business Overview
12.4.3 Anika Therapeutics Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Anika Therapeutics Corticosteroid Injections for Joint Pain Products Offered
12.4.5 Anika Therapeutics Recent Development
12.5 Ferring
12.5.1 Ferring Corporation Information
12.5.2 Ferring Description and Business Overview
12.5.3 Ferring Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Ferring Corticosteroid Injections for Joint Pain Products Offered
12.5.5 Ferring Recent Development
12.6 Bioventus
12.6.1 Bioventus Corporation Information
12.6.2 Bioventus Description and Business Overview
12.6.3 Bioventus Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Bioventus Corticosteroid Injections for Joint Pain Products Offered
12.6.5 Bioventus Recent Development
12.7 Flexion Therapeutics
12.7.1 Flexion Therapeutics Corporation Information
12.7.2 Flexion Therapeutics Description and Business Overview
12.7.3 Flexion Therapeutics Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Flexion Therapeutics Corticosteroid Injections for Joint Pain Products Offered
12.7.5 Flexion Therapeutics Recent Development
12.8 Zimmer Biomet
12.8.1 Zimmer Biomet Corporation Information
12.8.2 Zimmer Biomet Description and Business Overview
12.8.3 Zimmer Biomet Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Zimmer Biomet Corticosteroid Injections for Joint Pain Products Offered
12.8.5 Zimmer Biomet Recent Development
12.9 SEIKAGAKU
12.9.1 SEIKAGAKU Corporation Information
12.9.2 SEIKAGAKU Description and Business Overview
12.9.3 SEIKAGAKU Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2016-2021)
12.9.4 SEIKAGAKU Corticosteroid Injections for Joint Pain Products Offered
12.9.5 SEIKAGAKU Recent Development
12.10 Chugai Pharma
12.10.1 Chugai Pharma Corporation Information
12.10.2 Chugai Pharma Description and Business Overview
12.10.3 Chugai Pharma Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Chugai Pharma Corticosteroid Injections for Joint Pain Products Offered
12.10.5 Chugai Pharma Recent Development
12.11 Allergan
12.11.1 Allergan Corporation Information
12.11.2 Allergan Description and Business Overview
12.11.3 Allergan Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Allergan Corticosteroid Injections for Joint Pain Products Offered
12.11.5 Allergan Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Corticosteroid Injections for Joint Pain Industry Trends
13.2 Corticosteroid Injections for Joint Pain Market Drivers
13.3 Corticosteroid Injections for Joint Pain Market Challenges
13.4 Corticosteroid Injections for Joint Pain Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Corticosteroid Injections for Joint Pain Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Corticosteroid Injections for Joint Pain Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Knee & Ankle
Table 3. Major Manufacturers of Hip Joint
Table 4. Major Manufacturers of Shoulder & Elbow
Table 5. Major Manufacturers of Facet Joints of the Spine
Table 6. Major Manufacturers of Others
Table 7. Global Corticosteroid Injections for Joint Pain Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 8. Global Corticosteroid Injections for Joint Pain Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 9. Global Corticosteroid Injections for Joint Pain Sales by Regions (2016-2021) & (K Units)
Table 10. Global Corticosteroid Injections for Joint Pain Sales Market Share by Regions (2016-2021)
Table 11. Global Corticosteroid Injections for Joint Pain Revenue by Regions (2016-2021) & (US$ Million)
Table 12. Global Corticosteroid Injections for Joint Pain Sales Forecast by Region (2022-2027) & (K Units)
Table 13. Global Corticosteroid Injections for Joint Pain Sales Market Share Forecast by Region (2022-2027)
Table 14. Global Corticosteroid Injections for Joint Pain Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 15. Global Corticosteroid Injections for Joint Pain Revenue Market Share Forecast by Region (2022-2027)
Table 16. Global Corticosteroid Injections for Joint Pain Sales by Manufacturers (2016-2021) (K Units)
Table 17. Global Corticosteroid Injections for Joint Pain Sales Share by Manufacturers (2016-2021)
Table 18. Ranking of Global Top Corticosteroid Injections for Joint Pain Manufacturers by Revenue (US$ Million) in 2020
Table 19. Corticosteroid Injections for Joint Pain Revenue by Manufacturers (2016-2021) (US$ Million)
Table 20. Corticosteroid Injections for Joint Pain Revenue Share by Manufacturers (2016-2021)
Table 21. Global Corticosteroid Injections for Joint Pain Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 22. Global Corticosteroid Injections for Joint Pain by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Corticosteroid Injections for Joint Pain as of 2020)
Table 23. Key Manufacturers Corticosteroid Injections for Joint Pain Price (2016-2021) (USD/Unit)
Table 24. Corticosteroid Injections for Joint Pain Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Corticosteroid Injections for Joint Pain Product Type
Table 26. Date of International Manufacturers Enter into Corticosteroid Injections for Joint Pain Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Corticosteroid Injections for Joint Pain Sales by Type (2016-2021) (K Units)
Table 29. Global Corticosteroid Injections for Joint Pain Sales Share by Type (2016-2021)
Table 30. Global Corticosteroid Injections for Joint Pain Revenue by Type (2016-2021) (US$ Million)
Table 31. Global Corticosteroid Injections for Joint Pain Revenue Share by Type (2016-2021)
Table 32. Corticosteroid Injections for Joint Pain Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Table 33. Global Corticosteroid Injections for Joint Pain Sales Forecast by Type (2022-2027) & (K Units)
Table 34. Global Corticosteroid Injections for Joint Pain Sales Market Share Forecast by Type (2022-2027)
Table 35. Global Corticosteroid Injections for Joint Pain Revenue Forecast V (2022-2027) & (US$ Million)
Table 36. Global Corticosteroid Injections for Joint Pain Revenue Market Share Forecast by Type (2022-2027)
Table 37. Global Corticosteroid Injections for Joint Pain Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit)
Table 38. Global Corticosteroid Injections for Joint Pain Sales by Application (2016-2021) (K Units)
Table 39. Global Corticosteroid Injections for Joint Pain Sales Share by Application (2016-2021)
Table 40. Global Corticosteroid Injections for Joint Pain Revenue by Application (2016-2021) (US$ Million)
Table 41. Global Corticosteroid Injections for Joint Pain Revenue Share by Application (2016-2021)
Table 42. Corticosteroid Injections for Joint Pain Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Table 43. Global Corticosteroid Injections for Joint Pain Sales Forecast by Application (2022-2027) & (K Units)
Table 44. Global Corticosteroid Injections for Joint Pain Sales Market Share Forecast by Application (2022-2027)
Table 45. Global Corticosteroid Injections for Joint Pain Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 46. Global Corticosteroid Injections for Joint Pain Revenue Market Share Forecast by Application (2022-2027)
Table 47. Global Corticosteroid Injections for Joint Pain Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit)
Table 48. Japan Corticosteroid Injections for Joint Pain Sales (K Units) of Key Companies (2016-2021)
Table 49. Japan Corticosteroid Injections for Joint Pain Sales Share by Company (2016-2021)
Table 50. Japan Corticosteroid Injections for Joint Pain Revenue (US$ Million) by Company (2016-2021)
Table 51. Japan Corticosteroid Injections for Joint Pain Revenue Share by Company (2016-2021)
Table 52. Japan Corticosteroid Injections for Joint Pain Sales (K Units) by Type (2016-2021)
Table 53. Japan Corticosteroid Injections for Joint Pain Sales Share by Type (2016-2021)
Table 54. Japan Corticosteroid Injections for Joint Pain Revenue (US$ Million) Market Share by Type (2016-2021)
Table 55. Japan Corticosteroid Injections for Joint Pain Price (USD/Unit) by Type (2016-2021)
Table 56. Japan Corticosteroid Injections for Joint Pain Sales (K Units) by Type (2022-2027)
Table 57. Japan Corticosteroid Injections for Joint Pain Sales Share by Type (2022-2027)
Table 58. Japan Corticosteroid Injections for Joint Pain Revenue (US$ Million) Market Share by Type (2022-2027)
Table 59. Japan Corticosteroid Injections for Joint Pain Revenue Share by Type (2022-2027)
Table 60. Japan Corticosteroid Injections for Joint Pain Price (USD/Unit) by Type (2022-2027)
Table 61. Japan Corticosteroid Injections for Joint Pain Sales (K Units) by Application (2016-2021)
Table 62. Japan Corticosteroid Injections for Joint Pain Sales Share by Application (2016-2021)
Table 63. Japan Corticosteroid Injections for Joint Pain Revenue (US$ Million) Market Share by Application (2016-2021)
Table 64. Japan Corticosteroid Injections for Joint Pain Price (USD/Unit) by Application (2016-2021)
Table 65. Japan Corticosteroid Injections for Joint Pain Sales (K Units) by Application (2022-2027)
Table 66. Japan Corticosteroid Injections for Joint Pain Sales Share by Application (2022-2027)
Table 67. Japan Corticosteroid Injections for Joint Pain Revenue (US$ Million) Market Share by Application (2022-2027)
Table 68. Japan Corticosteroid Injections for Joint Pain Revenue Share by Application (2022-2027)
Table 69. Japan Corticosteroid Injections for Joint Pain Price (USD/Unit) by Application (2022-2027)
Table 70. North America Corticosteroid Injections for Joint Pain Sales by Country (2016-2021) & (K Units)
Table 71. North America Corticosteroid Injections for Joint Pain Sales Market Share by Country (2016-2021)
Table 72. North America Corticosteroid Injections for Joint Pain Revenue by Country (2016-2021) & (US$ Million)
Table 73. North America Corticosteroid Injections for Joint Pain Revenue Market Share by Country (2016-2021)
Table 74. Asia Pacific Corticosteroid Injections for Joint Pain Sales by Region (2016-2021) & (K Units)
Table 75. Asia Pacific Corticosteroid Injections for Joint Pain Sales Market Share by Region (2016-2021)
Table 76. Asia Pacific Corticosteroid Injections for Joint Pain Revenue by Region (2016-2021) & (US$ Million)
Table 77. Asia Pacific Corticosteroid Injections for Joint Pain Revenue Market Share by Region (2016-2021)
Table 78. Europe Corticosteroid Injections for Joint Pain Sales by Country (2016-2021) & (K Units)
Table 79. Europe Corticosteroid Injections for Joint Pain Sales Market Share by Country (2016-2021)
Table 80. Europe Corticosteroid Injections for Joint Pain Revenue by Country (2016-2021) & (US$ Million)
Table 81. Europe Corticosteroid Injections for Joint Pain Revenue Market Share by Country (2016-2021)
Table 82. Latin America Corticosteroid Injections for Joint Pain Sales by Country (2016-2021) & (K Units)
Table 83. Latin America Corticosteroid Injections for Joint Pain Sales Market Share by Country (2016-2021)
Table 84. Latin Americaa Corticosteroid Injections for Joint Pain Revenue by Country (2016-2021) & (US$ Million)
Table 85. Latin America Corticosteroid Injections for Joint Pain Revenue Market Share by Country (2016-2021)
Table 86. Middle East and Africa Corticosteroid Injections for Joint Pain Sales by Country (2016-2021) & (K Units)
Table 87. Middle East and Africa Corticosteroid Injections for Joint Pain Sales Market Share by Country (2016-2021)
Table 88. Middle East and Africa Corticosteroid Injections for Joint Pain Revenue by Country (2016-2021) & (US$ Million)
Table 89. Middle East and Africa Corticosteroid Injections for Joint Pain Revenue Market Share by Country (2016-2021)
Table 90. Allergan Corporation Information
Table 91. Allergan Description and Business Overview
Table 92. Allergan Corticosteroid Injections for Joint Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 93. Allergan Corticosteroid Injections for Joint Pain Product
Table 94. Allergan Recent Development
Table 95. Pfizer Corporation Information
Table 96. Pfizer Description and Business Overview
Table 97. Pfizer Corticosteroid Injections for Joint Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 98. Pfizer Product
Table 99. Pfizer Recent Development
Table 100. Sanofi Corporation Information
Table 101. Sanofi Description and Business Overview
Table 102. Sanofi Corticosteroid Injections for Joint Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 103. Sanofi Product
Table 104. Sanofi Recent Development
Table 105. Anika Therapeutics Corporation Information
Table 106. Anika Therapeutics Description and Business Overview
Table 107. Anika Therapeutics Corticosteroid Injections for Joint Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 108. Anika Therapeutics Product
Table 109. Anika Therapeutics Recent Development
Table 110. Ferring Corporation Information
Table 111. Ferring Description and Business Overview
Table 112. Ferring Corticosteroid Injections for Joint Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Ferring Product
Table 114. Ferring Recent Development
Table 115. Bioventus Corporation Information
Table 116. Bioventus Description and Business Overview
Table 117. Bioventus Corticosteroid Injections for Joint Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Bioventus Product
Table 119. Bioventus Recent Development
Table 120. Flexion Therapeutics Corporation Information
Table 121. Flexion Therapeutics Description and Business Overview
Table 122. Flexion Therapeutics Corticosteroid Injections for Joint Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Flexion Therapeutics Product
Table 124. Flexion Therapeutics Recent Development
Table 125. Zimmer Biomet Corporation Information
Table 126. Zimmer Biomet Description and Business Overview
Table 127. Zimmer Biomet Corticosteroid Injections for Joint Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Zimmer Biomet Product
Table 129. Zimmer Biomet Recent Development
Table 130. SEIKAGAKU Corporation Information
Table 131. SEIKAGAKU Description and Business Overview
Table 132. SEIKAGAKU Corticosteroid Injections for Joint Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. SEIKAGAKU Product
Table 134. SEIKAGAKU Recent Development
Table 135. Chugai Pharma Corporation Information
Table 136. Chugai Pharma Description and Business Overview
Table 137. Chugai Pharma Corticosteroid Injections for Joint Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Chugai Pharma Product
Table 139. Chugai Pharma Recent Development
Table 140. Corticosteroid Injections for Joint Pain Market Trends
Table 141. Corticosteroid Injections for Joint Pain Market Drivers
Table 142. Corticosteroid Injections for Joint Pain Market Challenges
Table 143. Corticosteroid Injections for Joint Pain Market Restraints
Table 144. Corticosteroid Injections for Joint Pain Customers List
Table 145. Corticosteroid Injections for Joint Pain Distributors List
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Corticosteroid Injections for Joint Pain Product Picture
Figure 2. Global Corticosteroid Injections for Joint Pain Sales Market Share by Type in 2020 & 2027
Figure 3. Knee & Ankle Product Picture
Figure 4. Hip Joint Product Picture
Figure 5. Shoulder & Elbow Product Picture
Figure 6. Facet Joints of the Spine Product Picture
Figure 7. Others Product Picture
Figure 8. Global Corticosteroid Injections for Joint Pain Sales Market Share by Application in 2020 & 2027
Figure 9. Hospital Pharmacies
Figure 10. Retail Pharmacies
Figure 11. Online Pharmacies
Figure 12. Corticosteroid Injections for Joint Pain Report Years Considered
Figure 13. Global Corticosteroid Injections for Joint Pain Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Corticosteroid Injections for Joint Pain Market Size 2016-2027 (US$ Million)
Figure 15. Global Corticosteroid Injections for Joint Pain Sales 2016-2027 (K Units)
Figure 16. Global Corticosteroid Injections for Joint Pain Market Size Market Share by Region: 2021 Versus 2027
Figure 17. Global Corticosteroid Injections for Joint Pain Sales Market Share by Region (2016-2021)
Figure 18. Global Corticosteroid Injections for Joint Pain Sales Market Share by Region in 2020
Figure 19. Global Corticosteroid Injections for Joint Pain Revenue Market Share by Region (2016-2021)
Figure 20. Global Corticosteroid Injections for Joint Pain Revenue Market Share by Region in 2020
Figure 21. Global Corticosteroid Injections for Joint Pain Sales Share by Manufacturer in 2020
Figure 22. The Top 10 and 5 Players Market Share by Corticosteroid Injections for Joint Pain Revenue in 2020
Figure 23. Corticosteroid Injections for Joint Pain Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 24. Global Corticosteroid Injections for Joint Pain Sales Market Share by Type (2016-2021)
Figure 25. Global Corticosteroid Injections for Joint Pain Sales Market Share by Type in 2020
Figure 26. Global Corticosteroid Injections for Joint Pain Revenue Market Share by Type (2016-2021)
Figure 27. Global Corticosteroid Injections for Joint Pain Revenue Market Share by Type in 2020
Figure 28. Global Corticosteroid Injections for Joint Pain Sales Market Share by Application (2016-2021)
Figure 29. Global Corticosteroid Injections for Joint Pain Sales Market Share by Application in 2020
Figure 30. Global Corticosteroid Injections for Joint Pain Revenue Market Share by Application (2016-2021)
Figure 31. Global Corticosteroid Injections for Joint Pain Revenue Market Share by Application in 2020
Figure 32. Japan Corticosteroid Injections for Joint Pain Sales Growth Rate 2016-2027 (K Units)
Figure 33. Japan Corticosteroid Injections for Joint Pain Revenue Growth Rate 2016-2027 (US$ Million)
Figure 34. Japan Corticosteroid Injections for Joint Pain Market Share in Global Market 2016-2027
Figure 35. Japan 5 and 10 Largest Corticosteroid Injections for Joint Pain Players Market Share by Revenue in Corticosteroid Injections for Joint Pain in 2020
Figure 36. Japan Corticosteroid Injections for Joint Pain Revenue Share by Type (2016-2021)
Figure 37. Japan Corticosteroid Injections for Joint Pain Revenue Growth Rate by Type in 2016 & 2020
Figure 38. Japan Corticosteroid Injections for Joint Pain Revenue Share by Application (2016-2021)
Figure 39. Japan Corticosteroid Injections for Joint Pain Revenue Growth Rate by Application in 2016 & 2020
Figure 40. North America Corticosteroid Injections for Joint Pain Sales Growth Rate 2016-2021 (K Units)
Figure 41. North America Corticosteroid Injections for Joint Pain Revenue Growth Rate 2016-2021 (US$ Million)
Figure 42. North America Corticosteroid Injections for Joint Pain Sales Market Share by Country in 2020
Figure 43. North America

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs